Fusen Pharmaceutical Company Limited (HKG:1652)

Hong Kong · Delayed Price · Currency is HKD

1.110

+0.040 (3.74%)

At close: Mar 10, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Shuanghuanglian Oral Solutions and Shuanghuanglian Injections	326.03M	565.61M	491.76M	385.66M	486.85M
Shuanghuanglian Oral Solutions and Shuanghuanglian Injections Growth	-42.36%	15.02%	27.51%	-20.78%	19.51%
Total	326.03M	565.61M	491.76M	385.66M	486.85M
Total Growth	-42.36%	15.02%	27.51%	-20.78%	19.51%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
People's Republic of China (PRC)	326.03M	565.61M	491.76M	385.66M	486.85M
People's Republic of China (PRC) Growth	-42.36%	15.02%	27.51%	-20.78%	19.51%
Total	326.03M	565.61M	491.76M	385.66M	486.85M
Total Growth	-42.36%	15.02%	27.51%	-20.78%	19.51%

Source: S&P Global Market Intelligence.